C - Chemistry – Metallurgy – 07 – K
Patent
C - Chemistry, Metallurgy
07
K
C07K 16/46 (2006.01) A61K 39/395 (2006.01) A61P 35/00 (2006.01) C07K 16/28 (2006.01) C12N 15/13 (2006.01)
Patent
CA 2691322
The present invention provides materials and methods for treatment of diseases involving aberrant B-cell activity, using a CD20-specific binding molecule, in particular, antibodies or antigen binding fragment thereof. The compositions disclosed herein is useful for the treatment and diagnosis of B-cell disorders, such as B-cell malignancies and autoimmune diseases.
La présente invention porte sur des matières et des procédés pour le traitement de maladies mettant en jeu une activité aberrante des lymphocytes B, à l'aide d'une molécule de liaison spécifique à CD-20, en particulier, des anticorps ou un fragment de liaison à un antigène de ceux-ci. Les compositions décrites ici sont utiles pour le traitement et le diagnostic de troubles des lymphocytes B, tels que des tumeurs malignes de lymphocytes B et des maladies auto-immunes.
Alan Ledbetter Jeffrey
Alexander Simon Sandy
Brady William
Damle Nitin K.
Dunussi-Joannopoulos Kyriaki
Smart & Biggar
Trubion Pharmaceuticals Inc.
Wyeth
Wyeth Llc
LandOfFree
Anti-cd20 therapeutic compositions and methods does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anti-cd20 therapeutic compositions and methods, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-cd20 therapeutic compositions and methods will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1706351